Zepbound 2.5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FN3HY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,061
Award facts
- Contract value 100% obligated
- $6,061.27 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Zepbound (semaglutide) 2.5 mg/0.5 mL pens valued at $6,061.27. This is a firm fixed-price delivery order with no set-aside designation, utilizing competitive procedures. The order is scheduled for ultimate completion on July 24, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract, this delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at approximately $1 billion and running through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems through the Defense Health Agency and other government healthcare entities. The company demonstrates substantial capability in fulfilling federal pharmaceutical requirements, as evidenced by its expansive IDC portfolio encompassing specialty medications, vaccines, and medical supplies across multiple therapeutic domains. This delivery order for Zepbound, a diabetes medication, reflects the company's ongoing role in supplying critical pharmaceutical commodities to support military healthcare programs. The DLA Medical Supply Chain has indicated plans to expand its Pharmaceutical Prime Vendor Global Program Generation V with multiple regional awards, positioning AmerisourceBergen among key strategic vendors for federal pharmaceutical distribution.
Quick answers
Who was awarded contract SPE2DB25FN3HY?
SPE2DB25FN3HY was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 23, 2025.
How much is contract SPE2DB25FN3HY worth?
The government has obligated $6,061 on SPE2DB25FN3HY.
Is contract SPE2DB25FN3HY an order under another contract?
Yes. SPE2DB25FN3HY is a delivery order under SPE2DB22D1200, an indefinite delivery contract.
Was contract SPE2DB25FN3HY competed?
The extent of competition for SPE2DB25FN3HY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award